当前位置:首页 - 行情中心 - 华兰生物(002007) - 财务分析 - 利润表

华兰生物

(002007)

  

流通市值:489.87亿  总市值:571.05亿
流通股本:12.04亿   总股本:14.03亿

利润表

按照会计年度查询:
报告期2019-09-302019-06-302019-03-312018-12-31
一、营业总收入2,638,440,901.591,402,608,966.25695,786,897.013,216,898,722.53
营业收入2,638,440,901.591,402,608,966.25695,786,897.013,216,898,722.53
二、营业总成本1,536,440,474.31849,451,691.09400,942,825.282,028,280,246.3
营业成本965,513,517.05571,631,828.75232,710,062.971,126,596,952.64
营业税金及附加21,958,187.8513,344,416.86,019,881.5428,073,638.07
销售费用293,494,455.22100,524,558.1978,663,930.98537,830,764.97
管理费用154,468,647.9497,992,123.4450,278,434.31181,834,729.61
财务费用-4,071,967.77-2,241,412.95-138,918.97555,328.41
资产减值损失-12,584,300.96-1,083,371.87-380.556,929,488.59
三、其他经营收益--------
允许价值变动净收益--------
投资净收益101,829,948.4440,420,942.714,133,023.83114,842,545.5
联营、合营企业投资收益18,799,920.44-10,848,111.28-8,850,593.821,013,646.1
汇兑净收益--------
四、营业利润1,210,927,561.37609,535,288.75308,984,430.551,391,428,971.23
营业外收入2,171,616.181,774,707.123,896,007.18,405,933
营业外支出5,098,145.273,636,991.143,446,665.859,974,881.99
非流动资产处置净损失--------
五、利润总额1,208,001,032.28607,673,004.73309,433,771.81,389,860,022.24
所得税192,114,131.14109,544,254.854,824,919.01180,322,304.54
未确认的投资损失--------
六、净利润(百万元)963.81506.98259.511,139.51
少数股东损益52,071,933.32-8,848,265.15-4,897,251.4870,024,780.92
归属于母公司股东的净利润963,814,967.82506,977,015.08259,506,104.271,139,512,936.78
七、每股收益0.690.360.281.23
基本每股收益0.690.360.281.23
稀释每股收益0.690.360.281.23
TOP↑